The Safety and Efficacy of Lansoprazole plus Metoclopramide among Neonates with Gastroesophageal Reflux Disease Resistant to Conservative Therapy and Monotherapy: A Clinical Trial

Table 2

Demographic characteristics in two intervention groups.

Demographic characteristics	Ranitidine plus metoclopramide (group A)	Lansoprazole plus metoclopramide (group B)	value
Gender
Girls, (%)	31 (57.4%)	28 (51.9%)	0.564
Boys, (%)	23 (42.6%)	26 (48.1%)
Age at intervention, , days			0.321
Birth weight, , g			0.474
Weight at presentation, , g			0.835
Gestational age at birth, ,			0.216
Total scoring at presentation,			0.263